With a budget of $8 million, two UdeM scientists at the Montreal Clinical Research Institute are probing the causes of neurological diseases and disorders such as autism, looking for new treatments.
An UdeM molecular biologist at the Maisonneuve-Rosemont Hospital Research Centre discovers a new function for BMI1, which is known to counteract brain aging.
Researchers at the CRCHUM find that metformin could help people living with HIV who are being treated with antiretroviral therapy.
Researchers at UdeM and Université Laval get $2.2 million to measure the impact of the pandemic on food workers in grocery stores, restaurants and bars.
UdeM neuroscientist Catherine Larochelle leads a study at the CHUM Research Centre that finds that a set of immune alterations are specifically linked to infection with the SARS-CoV-2 virus.
Researchers at UdeM and in Ontario and British Columbia will try to determine the prevalence of the disease among teachers and education workers, as well the pandemic’s effect on their mental health.
UdeM researcher Anick Bérard receives $3 million to study the use of medications by expectant mothers in Canada, analyzing data from 1998 through 2020 in five Canadian provinces.
Michel Bouvier, the Killam Prize-winning director of UdeM’s Institute for Research in Immunology and Cancer, unveils research that could someday lead to treatment for early morbid familial obesity.
Led by UdeM infectious-diseases specialist Emilia Liana Falcone, a multidisciplinary team at the Montreal Clinical Research Institute will look at long-term complications affecting COVID-19 survivors.
With a San Francisco biotech company, an UdeM eye expert develops a treatment that could potentially treat patients who suffer from this degenerative disease of the retina.